The findings were presented Thursday, Oct. 15, at TCT Connect 2020.

The findings were presented Wednesday, Oct. 14, during TCT Connect 2020. 

The role of ACE inhibitors and ARBs in the treatment of COVID-19 has been a key topic for researchers since the pandemic began. This latest research represents a significant update for clinicians. 

ACC.21 will now take place May 15-17, 2021, in Atlanta.

Researchers detailed a method that improves patient safety and leads to significant cost savings.

The BRACE CORONA trial focused on the safety of taking angiotensin-converting enzyme inhibitors and angiotensin receptor blockers when hospitalized with COVID-19.

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

The noninvasive technique shows potential where cardiac magnetic resonance imaging falls short.

The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less.

The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.

Nurses are unhappy with their working conditions, which leads to stress and exhaustion.